Professional
Added to YB: 2024-08-08
Pitch date: 2024-08-06
MEIP [bullish]
Lite Strategy, Inc.
-50.32%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
Market Cap
$71.7M
Pitch Price
$3.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.14
P/E
-0.84
EV/Sales
N/A
Sector
Biotechnology
Category
value
Show full summary:
GreenWood Investors Portfolio Holding: MEI Pharma, Inc.
MEIP: Biotech undervalued below worst-case balance sheet scenario. 30%+ insider ownership. Workforce reduction & strategic alternatives review to maximize asset value. Win-win: upside if drugs work, downside protected. Expecting positive resolution in coming quarters.
Read full article (1 min)